Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Cardiovascular Research, 2023

Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease

Davidsson P., Eketjäll S., Eriksson N. et al.

Ocular Immunology and Inflammation, 2023

Non-Infectious Uveitis Secondary to Dupilumab Treatment in Atopic Dermatitis Patients Shows a Pro-Inflammatory Molecular Profile

Achten R., van Luijk C., Thijs J. et al.

eBioMedicine, 2023

Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosis

Bakhshi H., Michelhaugh S., Bruce S. et al.

Biomedicines, 2023

Inflammatory Blood Signature Related to Common Psychological Comorbidity in Chronic Pain

Karshikoff B., Wåhlén K., Åström J. et al.

Arthritis Research & Therapy, 2023

TGF-β is elevated in hyperuricemic individuals and mediates urate-induced hyperinflammatory phenotype in human mononuclear cells

Klück V., Cabău G., Mies L. et al.

PROTEOMICS – Clinical Applications, 2023

Analytical validation of a multi‐protein, serum‐based assay for disease activity assessments in multiple sclerosis

Qureshi F., Hu W., Loh L. et al.

Cytopathology, 2023

Multiplex protein analysis and ensemble machine learning methods of fine needle aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumour grade

Röbeck P., Franzén B., Cantera‐Ahlman R. et al.

Molecular Medicine, 2023

Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning

Patel M., Knauer M., Nicholson M. et al.

Alzheimer's & Dementia, 2023

Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology

Wolzak K., Vermunt L., Campo M. et al.

Respiratory Research, 2023

Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia

Palma Medina L., Babačić H., Dzidic M. et al.

Journal of the Endocrine Society, 2023

Association Between Metabolic Syndrome Inflammatory Biomarkers and COVID-19 Severity

Pham T., Zu Y., Ghamsari F. et al.

Nature Metabolism, 2023

Proteogenomic mapping sets stage for precision medicine

Coral D., Franks P.

Nature Metabolism, 2023

Proteogenomic links to human metabolic diseases

Koprulu M., Carrasco-Zanini J., Wheeler E. et al.

Nature Communications, 2023

11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

Othonos N., Pofi R., Arvaniti A. et al.

JCI Insight, 2023

Vitamin D3 and deconvoluting a rash

Ernst M., Evans S., Techner J. et al.

Journal of Allergy and Clinical Immunology, 2023

Proteomic and transcriptomic screening demonstrates increased mast cell–derived CCL23 in systemic mastocytosis

Söderlund S., Boey D., van Midden W. et al.

Life Science Alliance, 2023

Plasma proteome dynamics of COVID-19 severity learnt by a graph convolutional network of multi-scale topology

Gauthier S., Tran-Dinh A., Morilla I.

Gut Microbes, 2023

Randomized controlled trial demonstrates response to a probiotic intervention for metabolic syndrome that may correspond to diet

Wastyk H., Perelman D., Topf M. et al.

Inflammation Research, 2023

Screening inflammatory protein biomarkers on premature infants with necrotizing enterocolitis

Dong H., Zhang L., Li B. et al.

The Journal of Clinical Endocrinology & Metabolism, 2023

Disease Duration and Chronic Complications Associate With Immune Activation in Individuals With Longstanding Type 1 Diabetes

Ajie M., van Heck J., Janssen A. et al.

4586 publications